Mechanistic analysis reveals pulmonary artery smooth muscle cell senescence drives vascular remodeling in chronic lung disease, highlighting cellular aging as a therapeutic target.
PA-SMC senescence is an important contributor to the process of pulmonary vascular remodeling that underlies pulmonary hypertension in chronic lung disease.
No takes yet. Share an insight, caveat, or question.
Noureddine et al. (2011) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: